ICU Medical Inc
ICUI: XNAS (USA)
| Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
|---|---|---|---|
| BLD | LOCK|F<y | LOCK|Gtn&@$W |
ICU Medical Earnings: Incremental Operational Improvements Could Provide Profit Catalysts in 2026
For the fourth quarter, ICU Medical delivered 2% organic revenue growth year over year and expanded gross margin to 38%, up from 36% a year ago. The company provided 2026 guidance featuring an adjusted EPS midpoint of $8.10, which would represent 5.3% growth over 2025.
